Ideaya Biosciences announces $200M common stock offering
PremiumThe FlyIdeaya Biosciences announces $200M common stock offering
17d ago
Ideaya Biosciences price target raised to $62 from $55 at BTIG
PremiumThe Fly
Ideaya Biosciences price target raised to $62 from $55 at BTIG
18d ago
Ideaya Biosciences price target raised to $60 from $53 at Oppenheimer
PremiumThe Fly
Ideaya Biosciences price target raised to $60 from $53 at Oppenheimer
18d ago
IDEAYA Biosciences Announces Chief Legal Officer’s Resignation
PremiumCompany AnnouncementsIDEAYA Biosciences Announces Chief Legal Officer’s Resignation
30d ago
Ideaya announces first-patient-in for Phase 1 trial of IDE397 with Trodelvy
PremiumThe Fly
Ideaya announces first-patient-in for Phase 1 trial of IDE397 with Trodelvy
1M ago
Ideaya Biosciences announces clinical program updates for IDE397
PremiumThe Fly
Ideaya Biosciences announces clinical program updates for IDE397
1M ago
Ideaya Biosciences reports Q1 EPS (53c), consensus (51c)
PremiumThe FlyIdeaya Biosciences reports Q1 EPS (53c), consensus (51c)
3M ago
IDEAYA Biosciences, Inc. Reports First Quarter 2024 Financial Results and Provides Business Update
PremiumPress Releases
IDEAYA Biosciences, Inc. Reports First Quarter 2024 Financial Results and Provides Business Update
3M ago
Ideaya Biosciences announces selection of move-forward expansion dose for IDE397
PremiumThe Fly
Ideaya Biosciences announces selection of move-forward expansion dose for IDE397
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100